Advances of Endothelial Progenitor Cells in the Development of Depression

Nana Yang1,2, Shiyu Sun1, Guangqing Duan3

  • 1School of Bioscience and Technology, Weifang Medical University, Weifang, China.

Insights

Depression increases cardiovascular disease risk. This study reviews how endothelial progenitor cells (EPCs) are affected in depression, suggesting EPCs may be a new target for assessing depression severity and complications.

Area of Science:

  • Psychological Medicine
  • Cardiovascular Medicine
  • Cell Biology

Background:

  • Depression is a significant mental health disorder.
  • Increased depression severity correlates with higher risks of cardiovascular disease (CVD), including acute coronary syndrome (ACS).
  • Reduced numbers of endothelial progenitor cells (EPCs) have been observed in individuals with depression, but their functional impact remains unclear.

Purpose of the Study:

  • To review and synthesize current research on the role of EPCs in depression.
  • To explore the potential of EPCs as a biomarker for depression severity.
  • To investigate EPCs as a novel therapeutic or diagnostic target for depression and its associated CVD complications.

Main Methods:

  • Literature review and synthesis of existing studies.
  • Analysis of research on EPCs in patients with depression.
  • Examination of the relationship between EPCs and depression severity and CVD risk.

Main Results:

  • Studies indicate a decrease in peripheral blood EPC numbers in depressed patients.
  • The functional capacity of EPCs in the context of depression requires further investigation.
  • Evidence suggests a link between EPCs and the pathogenesis of depression and its cardiovascular sequelae.

Conclusions:

  • EPCs are implicated in the development of depression.
  • EPCs may serve as a valuable indicator for assessing depression severity.
  • Targeting EPCs could offer new avenues for managing depression and preventing CVD complications.